Movatterモバイル変換

[0]ホーム
URL:

MX9702357A - Spray-dried microparticles as therapeutic vehicles. - Google Patents

Spray-dried microparticles as therapeutic vehicles.

Info

Publication number
MX9702357A
MX9702357AMX9702357AMX9702357AMX9702357AMX 9702357 AMX9702357 AMX 9702357AMX 9702357 AMX9702357 AMX 9702357AMX 9702357 AMX9702357 AMX 9702357AMX 9702357 AMX9702357 AMX 9702357A
Authority
MX
Mexico
Prior art keywords
spray
dried microparticles
agent
therapeutic
therapeutic vehicles
Prior art date
Application number
MX9702357A
Other languages
Spanish (es)
Other versions
MXPA97002357A (en
Inventor
Andrew Derek Sutton
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris LtdfiledCriticalAndaris Ltd
Publication of MXPA97002357ApublicationCriticalpatent/MXPA97002357A/en
Publication of MX9702357ApublicationCriticalpatent/MX9702357A/en

Links

Classifications

Landscapes

Abstract

Translated fromSpanish

Las micropartículas de un material soluble en agua, que son suaves y esféricas, y por los menos 90% de las cuales tiene un tamaño de partícula medio de masa de 1 a 10 æm, y que llevan un agente terapéutico o diagnostico o el uso de dicho agente como el material soluble en agua, puede exitosamente utilizarse en inhaladores de polvo seco para surtir dicho agente.Microparticles of a water-soluble material, which are smooth and spherical, and at least 90% of which have a mass mean particle size of 1 to 10 æm, and which carry a therapeutic or diagnostic agent or the use of said agent as the water soluble material, can be successfully used in dry powder inhalers to supply said agent.

MX9702357A1994-09-291995-09-26Spray-dried microparticles as therapeutic vehicles.MX9702357A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
EP94307126.61994-09-29
EP943071261994-09-29
PCT/GB1995/002279WO1996009814A1 (en)1994-09-291995-09-26Spray-dried microparticles as therapeutic vehicles

Publications (2)

Publication NumberPublication Date
MXPA97002357A MXPA97002357A (en)1997-06-01
MX9702357Atrue MX9702357A (en)1997-06-28

Family

ID=8217866

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MX9702357AMX9702357A (en)1994-09-291995-09-26Spray-dried microparticles as therapeutic vehicles.

Country Status (16)

CountryLink
EP (1)EP0783298A1 (en)
JP (1)JPH10506406A (en)
KR (1)KR970705979A (en)
AU (1)AU701440B2 (en)
BR (1)BR9509171A (en)
CA (1)CA2199954A1 (en)
CZ (1)CZ92497A3 (en)
FI (1)FI971332A0 (en)
HU (1)HUT77373A (en)
MX (1)MX9702357A (en)
NO (1)NO971438L (en)
NZ (1)NZ292980A (en)
PL (1)PL319600A1 (en)
RU (1)RU2147226C1 (en)
WO (1)WO1996009814A1 (en)
ZA (1)ZA958239B (en)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6582728B1 (en)1992-07-082003-06-24Inhale Therapeutic Systems, Inc.Spray drying of macromolecules to produce inhaleable dry powders
BR9507023A (en)1994-03-071997-09-23Inhale Therapeutic Syst Processes for aerosolizing an insulin dose for respiratory insulin delivery and for preparing an insulin composition and insulin composition
US6051256A (en)1994-03-072000-04-18Inhale Therapeutic SystemsDispersible macromolecule compositions and methods for their preparation and use
US5955108A (en)*1994-12-161999-09-21Quadrant Healthcare (Uk) LimitedCross-linked microparticles and their use as therapeutic vehicles
GB9606188D0 (en)*1996-03-231996-05-29Danbiosyst UkPollysaccharide microspheres for the pulmonary delivery of drugs
GB9606677D0 (en)*1996-03-291996-06-05Glaxo Wellcome IncProcess and device
GB9607035D0 (en)*1996-04-031996-06-05Andaris LtdSpray-dried microparticles as therapeutic vehicles
GB9610341D0 (en)*1996-05-171996-07-24Andaris LtdFormulation for inhalation
AU702955B2 (en)*1996-05-171999-03-11Quadrant Healthcare (Uk) LimitedMicroparticles and their use in wound therapy
US5855913A (en)*1997-01-161999-01-05Massachusetts Instite Of TechnologyParticles incorporating surfactants for pulmonary drug delivery
US20020052310A1 (en)1997-09-152002-05-02Massachusetts Institute Of Technology The Penn State Research FoundationParticles for inhalation having sustained release properties
US5985309A (en)*1996-05-241999-11-16Massachusetts Institute Of TechnologyPreparation of particles for inhalation
USRE37053E1 (en)1996-05-242001-02-13Massachusetts Institute Of TechnologyParticles incorporating surfactants for pulmonary drug delivery
US5874064A (en)*1996-05-241999-02-23Massachusetts Institute Of TechnologyAerodynamically light particles for pulmonary drug delivery
US6254854B1 (en)1996-05-242001-07-03The Penn Research FoundationPorous particles for deep lung delivery
GB9615435D0 (en)1996-07-231996-09-04Andaris LtdSpray-dried product and its therapeutic use
GB9621825D0 (en)*1996-10-191996-12-11Andaris LtdMicroparticles and their use as therapeutic vehicles
US5961459A (en)*1996-10-191999-10-05Andaris LimitedUse of hollow microcapsules in diagnosis and therapy
AU6014098A (en)*1996-12-311998-07-31Inhale Therapeutic SystemsAerosolized hydrophobic drug
CA2277801C (en)*1997-01-162002-10-15Massachusetts Institute Of TechnologyPreparation of particles for inhalation
EP1498115A1 (en)*1997-01-162005-01-19Massachusetts Institute Of TechnologyPreparation of particles for inhalation
SE9700133D0 (en)*1997-01-201997-01-20Astra Ab New formulation
US7052678B2 (en)1997-09-152006-05-30Massachusetts Institute Of TechnologyParticles for inhalation having sustained release properties
EE04628B1 (en)*1997-09-292006-06-15Inhale Therapeutic Systems, Inc. Powder with Perforated Microstructures and Method for Preparing a Microparticle Composition and Powder with Perforated Microstructures
US6565885B1 (en)1997-09-292003-05-20Inhale Therapeutic Systems, Inc.Methods of spray drying pharmaceutical compositions
US6433040B1 (en)1997-09-292002-08-13Inhale Therapeutic Systems, Inc.Stabilized bioactive preparations and methods of use
US6309623B1 (en)1997-09-292001-10-30Inhale Therapeutic Systems, Inc.Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en)1997-09-292006-07-27Nektar TherapeuticsPulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en)1997-09-292005-09-20Nektar TherapeuticsStabilized preparations for use in nebulizers
SE9704186D0 (en)1997-11-141997-11-14Astra Ab New composition of matter
GB9727102D0 (en)*1997-12-221998-02-25Andaris LtdMicroparticles and their therapeutic use
AU2540299A (en)*1998-02-201999-09-06Quadrant Healthcare (Uk) LimitedProducts comprising fibrinogen for use in therapy
EP1273290A1 (en)*1998-06-242003-01-08Advanced Inhalation Research, Inc.Large porous particles emitted from an inhaler
EP1089712B1 (en)*1998-06-242003-05-02Advanced Inhalation Research, Inc.Large porous particles emitted from an inhaler
US6956021B1 (en)1998-08-252005-10-18Advanced Inhalation Research, Inc.Stable spray-dried protein formulations
ATE289825T1 (en)*1999-04-212005-03-151355540 Ontario Inc METHACOLINE OR HISTAMINE FORMULATIONS FOR DETECTING ASTHMA
US6858199B1 (en)2000-06-092005-02-22Advanced Inhalation Research, Inc.High efficient delivery of a large therapeutic mass aerosol
CA2395129C (en)1999-12-202008-12-16Nicholas J. KerkhofProcess for producing nanometer particles by fluid bed spray-drying
US8771740B2 (en)*1999-12-202014-07-08Nicholas J. KerkhofProcess for producing nanoparticles by spray drying
US7871598B1 (en)2000-05-102011-01-18Novartis AgStable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA02001323A (en)2000-05-102004-07-16Alliance PharmaPhospholipid-based powders for drug delivery.
WO2001093837A2 (en)*2000-06-082001-12-13Eli Lilly And CompanyProtein powder for pulmonary delivery
US7575761B2 (en)2000-06-302009-08-18Novartis Pharma AgSpray drying process control of drying kinetics
US6896906B2 (en)2000-12-212005-05-24Nektar TherapeuticsStorage stable powder compositions of interleukin-4 receptor
JP2005504715A (en)2000-12-292005-02-17アドバンスト インハレーション リサーチ，インコーポレイテッド Inhalable particles with sustained release characteristics
GB0111420D0 (en)*2001-05-102001-07-04Biovector Solutions LtdSoluble polymer systems for drug delivery
JP4837892B2 (en)2001-11-012011-12-14ネクター セラピューティクス Method for producing powder batch
DK1455755T3 (en)2001-11-202013-07-15Civitas Therapeutics Inc Improved particle composition for delivery in lung
ATE508735T1 (en)2001-12-192011-05-15Novartis Ag PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
US9339459B2 (en)2003-04-242016-05-17Nektar TherapeuticsParticulate materials
EP2526996B1 (en)2002-12-202019-09-11Xeris Pharmaceuticals, Inc.Formulation for intracutaneous injection
KR20120080243A (en)*2003-05-282012-07-16노바르티스 아게Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agent microparticle with a partial or complete amino acid and/or phospholipid coat
CA2532837A1 (en)2003-07-182005-04-21Baxter International, Inc.Method for preparing small spherical particles by controlled phase separation
DE10339197A1 (en)*2003-08-222005-03-24Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried amorphous powder with low residual moisture and good storage stability
US7723306B2 (en)2004-05-102010-05-25Boehringer Ingelheim Pharma Gmbh & Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7611709B2 (en)2004-05-102009-11-03Boehringer Ingelheim Pharma Gmbh And Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US7727962B2 (en)2004-05-102010-06-01Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
WO2005112893A1 (en)2004-05-122005-12-01Baxter International Inc.Microspheres comprising protein and showing injectability at high concentrations of said agent
RU2300369C1 (en)*2005-12-272007-06-10Наталья Ивановна ЛарионоваMethod for preparing polyelectolyte microparticles containing incapsulated substance and sensitive to environment composition alteration
US9017697B2 (en)2006-10-122015-04-28The University Of QueenslandCompositions and methods for modulating immune responses
EP2050437A1 (en)*2007-10-152009-04-22Laboratoires SMBImproved pharmaceutical dry powder compositions for inhalation.
UA90013C2 (en)*2008-03-192010-03-25Давид Анатолійович НогаPharmaceutical composition containing insulin and process for the preparation thereof
EP2349219A4 (en)2008-09-292013-05-01Univ Mercer BIOACTIVE ENCAPSULATION MATERIAL OF NANOSPHERES AND PROCESS FOR PREPARING NANOSPHERES
US10004790B2 (en)2008-09-292018-06-26The Corporation Of Mercer UniversityNanospheres encapsulating bioactive material and method for formulation of nanospheres
US11524058B2 (en)2008-09-292022-12-13The Corporation Of Mercer UniversityOral dissolving films containing microencapsulated vaccines and methods of making same
US10463608B2 (en)2008-09-292019-11-05The Corporation Of Mercer UniversityMicroneedle-based transdermal delivery system and method of making same
US9827205B2 (en)2008-12-122017-11-28Mallinckrodt Pharma Ip Trading D.A.C.Dry powder fibrin sealant
EP2216054A1 (en)2009-02-062010-08-11ProFibrix BVBiodegradable extravascular support
GB0909136D0 (en)2009-05-282009-07-01Profibrix BvDry powder composition
GB0909131D0 (en)2009-05-282009-07-01Quadrant Drug Delivery LtdDry powder fibrin sealant
AU2010252929B2 (en)*2009-05-282015-08-27Mallinckrodt Pharma Ip Trading D.A.C.Dry powder fibrin sealant
WO2011005756A1 (en)2009-07-062011-01-13Puretech Ventures, LlcDelivery of agents targeted to microbiota niches
US8846105B2 (en)2010-01-082014-09-30Profibrix, B.V.Dry powder fibrin sealant
WO2012012460A1 (en)2010-07-192012-01-26Xeris Pharmaceuticals, Inc.Stable glucagon formulations for the treatment of hypoglycemia
BR112013010926A2 (en)2010-11-012016-08-23Univ Technology Sidney immunomodulatory agents and their uses
CN103442695B (en)2011-03-102016-05-04Xeris药物公司 Stable Formulation of Peptide Drugs for Parenteral Injection
EP3225235B1 (en)2011-03-102020-12-16Xeris Pharmaceuticals, Inc.Stable peptide formulations for parenteral injection
RU2013155713A (en)2011-07-062015-08-20Профибрикс Бв COMPOSITIONS FOR TREATMENT OF THE RAS
BR112014010275A2 (en)2011-10-312017-04-18Xeris Pharmaceuticals Inc diabetes treatment formulations
KR20140147891A (en)2012-04-132014-12-30글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드Aggregate particles
KR102139393B1 (en)*2012-06-262020-07-29지이 헬스케어 에이에스Preparation of composition comprising gas microbubbles
US9125805B2 (en)2012-06-272015-09-08Xeris Pharmaceuticals, Inc.Stable formulations for parenteral injection of small molecule drugs
KR20150139830A (en)2013-02-012015-12-14글리아로직스 인코포레이티드Compositions and methods for the treatment of neurodegenerative and other diseases
US9956287B2 (en)2013-02-062018-05-01Perosphere Inc.Stable glucagon formulations
US9018162B2 (en)2013-02-062015-04-28Xeris Pharmaceuticals, Inc.Methods for rapidly treating severe hypoglycemia
CN113768881A (en)2013-10-082021-12-10人工智能治疗公司Rapamycin for the treatment of lymphangioleiomyomatosis
MX394266B (en)2014-04-042025-03-24Ai Therapeutics Inc AN INHALED RAPAMYCIN FORMULA FOR TREATING AGE-RELATED CONDITIONS.
EP3149049B1 (en)2014-05-272022-10-26The University Of QueenslandIl-22 for use in treating metabolic disorders
US11129940B2 (en)2014-08-062021-09-28Xeris Pharmaceuticals, Inc.Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
CA2963085C (en)2014-10-072023-02-21Lam Therapeutics, Inc.An inhalable rapamycin formulation for the treatment of pulmonary hypertension
WO2016196976A1 (en)2015-06-042016-12-08Xeris Pharmaceuticals, Inc.Glucagon delivery apparatuses and related methods
US9649364B2 (en)2015-09-252017-05-16Xeris Pharmaceuticals, Inc.Methods for producing stable therapeutic formulations in aprotic polar solvents
EP3307295A1 (en)2015-06-102018-04-18Xeris Pharmaceuticals, Inc.Use of low dose glucagon
US11590205B2 (en)2015-09-252023-02-28Xeris Pharmaceuticals, Inc.Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
US11628208B2 (en)2015-10-052023-04-18The Corporation Of Mercer UniversitySystem and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
WO2017062463A1 (en)2015-10-052017-04-13The Corporation Of Mercer UniversityNanospheres encapsulating bioactive material and method for formulation of nanospheres
US20180110760A1 (en)2016-10-212018-04-26Glialogix, Inc.Compositions and methods for the treatmentof neurodegenerative and other diseases
KR102646865B1 (en)2017-06-022024-03-11엑스에리스 파머수티클스, 인크. Precipitation-resistant small molecule drug formulation
WO2021090214A2 (en)*2019-11-042021-05-14Alesco S.R.L.Sucrosomial® berberine, its compositions and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE3917617A1 (en)*1989-05-311990-12-06Boehringer Ingelheim Kg MICRONIZED BIODEGRADABLE PARTICLES, PROCESS FOR THEIR PREPARATION AND THEIR USE
KR100208979B1 (en)*1992-06-121999-07-15야스이 쇼사꾸 Preparations for Intra-Air Administration
KR100277622B1 (en)*1992-06-122001-01-15이타가키 히로시 Inhalation ultrafine powder and its manufacturing method

Also Published As

Publication numberPublication date
HUT77373A (en)1998-03-30
FI971332A7 (en)1997-04-01
NO971438D0 (en)1997-03-26
KR970705979A (en)1997-11-03
FI971332L (en)1997-04-01
NO971438L (en)1997-03-26
PL319600A1 (en)1997-08-18
AU3530295A (en)1996-04-19
AU701440B2 (en)1999-01-28
WO1996009814A1 (en)1996-04-04
JPH10506406A (en)1998-06-23
ZA958239B (en)1996-09-30
CA2199954A1 (en)1996-04-04
EP0783298A1 (en)1997-07-16
FI971332A0 (en)1997-04-01
BR9509171A (en)1997-09-16
CZ92497A3 (en)1997-08-13
RU2147226C1 (en)2000-04-10
NZ292980A (en)1999-02-25

Similar Documents

PublicationPublication DateTitle
MX9702357A (en)Spray-dried microparticles as therapeutic vehicles.
AR007493A1 (en) SPRAY DRIED MICROPARTICLES AS THERAPEUTIC VEHICLES FOR USE IN GENETIC THERAPY
ES2067647T3 (en) PERFUME PARTICLES FOR USE IN CLEANING AND CONDITIONING COMPOSITIONS.
CO4600671A1 (en) SUSTAINED RELEASE CAFFEINE FORMULATION
ES2045386T3 (en) ORAL PREPARATIONS.
ES2191984T3 (en) MICROPARTICLES AND THEIR THERAPEUTIC OR DIAGNOSTIC USE.
BR0012351A (en) Powders consisting of particles with a perfectly smooth surface, for use as vehicles for the preparation of inhalation mixtures with micronized drugs and the method for their preparation
ES2129980T3 (en) MOISTURE SHAVING SYSTEM WITH A COMPOSITE MATERIAL THAT FAVORES SHAVING, WITH A COMPLEX OF INCLUSION OF A SKIN SOFTENING AGENT AND CYCLODEXTRIN.
BR0107869A (en) Electrogenated pharmaceutical compositions
BR9006924A (en) FORMULATION FOR THE TREATMENT OF SYMPTOMS AND DISEASES, USE OF FORMULATION FOR THE TREATMENT OF SYMPTOMS AND DISEASES, METHOD FOR THE TREATMENT OF SYMPTOMS AND DISEASES, DISTRIBUTION OF MEDICINAL AND THERAPEUTIC AGENTS FOR THE TREATMENT OF SYMPTOMS AND DISEASES IN COMBINATION
ES2189018T3 (en) USE OF POLYMER DUST OR GRANULATED POLYMER DUST REDISPERSABLE FOR THE COVERING OF PHARMACEUTICAL OR AGROCHEMICAL ADMINISTRATION FORMS.
AR017174A1 (en) DISPOSABLE MONOUSE PRODUCT FOR CLEANING AND PERSONAL CONDITIONING AND METHOD FOR MANUFACTURING
ES2183186T3 (en) COSMETIC COMPOSITIONS IN POWDER CONTAINING SILICONE ELASTOMEROS.
TR27082A (en) Overlaid perfume particles.
ES2151968T3 (en) HEMORROIDAL COMPOSITIONS AND METHOD OF USE.
ES2235311T8 (en) FORMULATION OF BUDESONIDE / FORMOTEROL FOR INHALATION THAT HAS AN APPEARING DENSITY OF DRAINAGE OF 0.30 TO 0.36 G / ML, A PROCESS TO PREPARE THE FORMULATION AND USE OF THE SAME.
ES2173930T3 (en) EXPANDED ARTICLES OF BIODEGRADABLE PLASTIC MATERIAL AND A PROCESS FOR THE PREPARATION OF THEMSELVES.
BR9509183A (en) Anti-inflammatory agent for external use
BR0015676A (en) Pesticidal composition, method to control pests, and, use of a storage stable aerated gel composition
IT1141482B (en) MIXED SALTS OF ESSENTIAL OR SEMI-ESSENTIAL AMINO ACIDS AND THEIR NON-NITROGEN ANALOGUES, AS WELL AS THEIR USE IN THE THERAPY OF RENAL AND HEPATIC DYSFUNCTIONS
TW280780B (en)
ES2231176T3 (en) USE OF BETA- (1,3) -NANOMETRIC GLANES HYDROSOLUBLES.
AR007178A1 (en) FORMULATION CONTAINING MICROPARTICLES, FOR INHALATION
RS50345B (en)Ciclesonide-containing aqueous pharmaceutical composition
PT871467E (en) FORMULATION FOR PEPTIDE LIBERATION
[8]ページ先頭
©2009-2025 Movatter.jp